- Investing Ideas
- /
- Top Growth Stocks
Top Global Healthcare Growth Stocks
UPDATED Jul 03, 2022
What are the best Global Healthcare Growth Stocks?
According to our Simply Wall St analysis these are the best Global Healthcare growth companies. We look for companies with high forecasted growth and healthy balance sheets that can deliver sustained growth over the long term.
Our criteria to find Top Growth Companies
Growth
- Companies with sustained revenue growth that outperforms the market are attractive to investors. These companies are most likely to appreciate in share price over time.
What do we look for?
- Is the company forecast to have high earnings growth.
Healthy Balance Sheet
- A healthy balance sheet is essential to drive growth opportunities and sustain the business.
- Repayments on debt take precedence over other initiatives to improve shareholder returns, so investors want to make sure the company is comfortably positioned to cover its debts.
What do we look for?
- Does the company have a manageable level of debt.
- Is the company able to cover its interest repayments.
50 companies meet this criteria in the Global market
Polynovo Limited develops medical devices in the United States, Australia, New Zealand, the United Kingdom, Ireland, Singapore, and internationally.
Growth Criteria
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings: PNV's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market
High Growth Revenue
Future ROE
Rewards
Trading at 48.5% below our estimate of its fair value
Earnings are forecast to grow 72.19% per year
Became profitable this year
Risks
Large one-off items impacting financial results
Mentice AB (publ) provides endovascular simulation solutions to teaching entities, healthcare systems, and medical device manufacturers.
Growth Criteria
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings: MNTC is expected to become profitable in the next 3 years.
Revenue vs Market
High Growth Revenue
Future ROE
Rewards
Trading at 44.2% below our estimate of its fair value
Earnings are forecast to grow 96.96% per year
Risks
Shareholders have been diluted in the past year
Kangji Medical Holdings Limited, through its subsidiaries, designs, develops, manufactures, and sale of minimally invasive surgical instruments and accessories in China.
Growth Criteria
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings: 9997's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market
High Growth Revenue
Future ROE
Rewards
Trading at 75.9% below our estimate of its fair value
Earnings are forecast to grow 20.39% per year
Earnings grew by 82.5% over the past year
Risks
High level of non-cash earnings
Jeisys Medical Inc. designs, develops, and manufactures medical device for plastic surgeons, dermatologist, physicians, and healthcare professionals.
Growth Criteria
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings: A287410's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market
High Growth Revenue
Future ROE
Rewards
Trading at 68.3% below our estimate of its fair value
Earnings are forecast to grow 21.03% per year
Became profitable this year
Risks
High level of non-cash earnings
Cogstate Limited, a cognitive science company, provides computerized cognitive tests for clinical trials, academic research, healthcare, and brain health applications in Australia and internationally.
Growth Criteria
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings: CGS's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market
High Growth Revenue
Future ROE
Rewards
Trading at 75.4% below our estimate of its fair value
Earnings are forecast to grow 26.96% per year
Earnings grew by 2812.4% over the past year
Risks
Large one-off items impacting financial results
Shenzhen New Industries Biomedical Engineering Co., Ltd., a bio-medical company, engages in the research, development, production, and sale of clinical laboratory instruments and in vitro diagnostic reagents to hospitals and laboratories in China and internationally.
Growth Criteria
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings: 300832's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market
High Growth Revenue
Future ROE
Rewards
Price-To-Earnings ratio (32x) is below the CN market (34.2x)
Earnings are forecast to grow 26.53% per year
Earnings grew by 11.8% over the past year
Risks
High level of non-cash earnings
Growth Criteria
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings: MDA's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market
High Growth Revenue
Future ROE
Rewards
Trading at 76.1% below our estimate of its fair value
Earnings are forecast to grow 43.64% per year
Earnings grew by 57.3% over the past year
Risks
High level of non-cash earnings
Does not have a meaningful market cap (PLN142M)
Does not have meaningful revenue (PLN14M)
Volatile share price over the past 3 months
Double Medical Technology Inc. provides services, technologies, and devices in the areas of orthopedics, wound management, neurosurgery, and general surgery in China.
Growth Criteria
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings: 002901's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market
High Growth Revenue
Future ROE
Rewards
Price-To-Earnings ratio (24.5x) is below the CN market (34.2x)
Earnings are forecast to grow 31.49% per year
Earnings have grown 20.4% per year over the past 5 years
Risks
High level of non-cash earnings
Shareholders have been diluted in the past year